Showing results 6 to 10 of 10
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Phase II multi-centre, dose-escalating study of LB80380 (ANA380) in hepatitis B patients with lamivudine-resistant YMDD mutant HBV Proceeding/Conference:Journal of Hepatology | 2006 | 195 | ||
2013 | 111 | |||
A phase IIb study of the efficacy and safety of LB80380 vs entecavir in treatment-naive patients with chronic hepatitis B Proceeding/Conference:Hepatology | 2011 | 97 | ||
2015 | 51 | |||
2011 | 39 |